MAR 20, 2019 11:39 AM PDT

First Drug for Postpartum Depression

WRITTEN BY: Nouran Amin

The U.S. Food and Drug Administration recently approved the first ever drug specifically for the treatment of postpartum depression--a common and often devastating condition for new mothers which interferes with the maternal-infant bond. The approval of the drug came after the success of two clinical trials."Postpartum depression is a serious condition that, when severe, can be life-threatening," noted the FDA's Dr. Tiffany Farchione, who is acting director of the Division of Psychiatry Products in the agency's Center for Drug Evaluation and Research. "Women may experience thoughts about harming themselves or harming their child."

The drug is called Zulesso (brexanolone) and would be delivered intravenously.

"There is tremendous stigma around postpartum depression for women. Many women experience great shame and feel inadequate as mothers if they struggle with depression at a time that is supposed to be joyous ," says Dr. Martha Wald, a psychiatrist and psychoanalyst at Duke University, in Winston-Salem, N.C. "Because of this stigma, many women choose to not seek help and endure great suffering in silence," she said. "Postpartum depression affects 15 to 20 percent of the general population, and at least half of this group goes untreated. As more targeted treatments like this become available, more mothers are likely to seek and benefit from treatment."

Zulesso is different than any other antidepressant as it specifically acts on the main inhibitory neurotransmitter system of the brain, the GABA system. The drug also cocnatins an aturally occurring steroid in the body—allopregnanolone. "Allopregnanolone is known to modulate the stress response system in humans, which has been shown to be abnormally functioning in women with postpartum depression," explained Dr. Kristina Deligiannidis, the lead investigator on the clinical trials that led to Zulesso's approval.

Source: MedicalXpress.com

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 17, 2019
Genetics & Genomics
NOV 17, 2019
DNA Construction Kit Could Drive Down Costs of Immune Therapy
Researchers at KU Leuven in Belgium have created a DNA construction kit that, when injected into muscle cells, enables sheep to produce new antibodies to f...
NOV 17, 2019
Drug Discovery & Development
NOV 17, 2019
Transplanted Brain Stem Cells Survive Without Anti-Rejection Drugs
Researchers at Johns Hopkins Medicine have successfully transplanted brain cells without the need of immune-suppressing drugs. Findings of the study were p...
NOV 17, 2019
Drug Discovery & Development
NOV 17, 2019
AI Exponentially Accelerates Drug Development
Research and development for new drugs is both an expensive and lengthy process, often lasting years, if not decades. With the development of artificial in...
NOV 17, 2019
Drug Discovery & Development
NOV 17, 2019
Evolutionary-Busting Cancer Drug
Researchers at the Institute of Cancer Research in London have discovered that a new type of drug that blocks treatment in cancers. The drug works by inhib...
NOV 17, 2019
Drug Discovery & Development
NOV 17, 2019
Can Aspirin Prevent a Brain Bleed?
Can aspirin prevent a brain bleed? To answer the questions, researchers rummaged through a database system looking to see an association between aspirin us...
NOV 17, 2019
Neuroscience
NOV 17, 2019
Does New Chinese Alzheimer's Drug Made from Seaweed Work?
It has been almost two decades since the last drug for Alzheimer’s was approved. Now, Chinese reglators have granted conditinal approval for a new dr...
Loading Comments...